Tetra Pharm Technologies
Biotech company focused on therapeutics targeting the endocannabinoid system
Tetra Pharm Technologies has raised €9.0M across 1 funding round from 5 investors, most recently a Series A round in Jan 2023. Based in Copenhagen, Denmark; active in Healthtech. Data as of Nov 2026.
Copenhagen, Denmarkwww.tetra-pharm.com ↗
Total raised
€9.0M
€9,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearTetra Pharm Technologies — funding by year — interactive chart.
Data table
| Tetra Pharm Technologies — funding by year | |
|---|---|
| 2023 | €9.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-26 | Series A | €9.0M | Enexis AB,Leafy Tunnel,Nesroht Holding,Ole GS Holding,Rump Invest | View deal → |
Related news
- Tetra Pharm Technologies Raises €9M in Series A Fundingfinsmes.com · 2023-01
Similar companies
same sector, similar size- Embla€10MDenmark · Healthtech
- Neurescue€10MDenmark · Healthtech
- Enduro Genetics€12MDenmark · Healthtech
- Hedia€8.7MDenmark · Healthtech
- Freya Biosciences€11MDenmark · Healthtech
- InProTher€6.0MDenmark · Healthtech
Global coverage: FundingData